2007 Publications

Publications resulting from human brain tissue obtained from the ABBN.

Alexander-Kaufman K, Harper C, Wilce P, and Matsumoto I. (2007) Cerebellar vermis proteome of chronic alcoholic individuals. Alcohol Clin Exp Res. 31: 1286-1296.


Alexander-Kaufman K, Cordwell S, Harper C, and Matsumoto I. (2007) A proteome analysis of the dorsolateral prefrontal cortex in human alcoholic patients. Proteomics Clin Appl. 1: 62-72.


Bowden NA, Scott RJ, and Tooney PA. (2007) Altered expression of regulator of G-protein signalling 4 (RGS4) mRNA in the superior temporal gyrus in schizophrenia. Schizophr Res. 89: 165-168.


Cai Z, Blumbergs PC, Finnie JW, Manavis J, and Thompson PD. (2007) Novel fibroblastic onion bulbs in a demyelinating avian peripheral neuropathy produced by riboflavin deficiency. Acta neuropathologica. 114: 187-194.


Clark D, Dedova I, Cordwell S, and Matsumoto I. (2007) Altered proteins of the anterior cingulate cortex white matter proteome in schizophrenia. Proteomics Clin Appl. 1: 157-166.


de las Heras R, Depaz I, Jaquet V, Kroon P, and Wilce PA. (2007) Neuronal protein 22 colocalises with both the microtubule and microfilament cytoskeleton in neurite-like processes. Brain research. 1128: 12-20.


Dean B, Boer SA, Mackinnon A, and Berk M. (2007) CNS 14-3-3ζ: changes with sex but not psychiatric diagnoses or psychotropic drug treatment. Schizophr Res. 93: 51-57.


Dean B, Keriakous D, Scarr E, and Thomas EA. (2007) Gene expression profiling in Brodmann's area 46 from subjects with schizophrenia. Aust N Z J Psychiatry. 41: 308-320.


Fodero-Tavoletti MT, Smith DP, McLean CA, Adlard PA, Barnham KJ, Foster LE, Leone L, Perez K, Cortes M, Culvenor JG, Li QX, Laughton KM, Rowe CC, Masters CL, Cappai R, and Villemagne VL. (2007) In vitro characterization of Pittsburgh compound-B binding to Lewy bodies. J Neurosci. 27: 10365-10371.


Guillemin GJ, Brew BJ, Noonan CE, Knight TG, and Cullen KM. (2007) Mass spectrometric detection of quinolinic acid in microdissected Alzheimer's disease plaques. International Congress Series. 1304: 404-408.


Harper C. (2007) The neurotoxicity of alcohol. Hum Exp Toxicol. 26: 251-257.


Hutchison KE, Allen DL, Filbey FM, Jepson C, Lerman C, Benowitz NL, Stitzel J, Bryan A, McGeary J, and Haughey HM. (2007) CHRNA4 and tobacco dependence: from gene regulation to treatment outcome. Arch Gen Psychiatry. 64: 1078-1086.


Ishiguro H, Iwasaki S, Teasenfitz L, Higuchi S, Horiuchi Y, Saito T, Arinami T, and Onaivi ES. (2007) Involvement of cannabinoid CB2 receptor in alcohol preference in mice and alcoholism in humans. Pharmacogenomics J. 7: 380-385.


Johansson S, Fuchs A, Okvist A, Karimi M, Harper C, Garrick T, Sheedy D, Hurd Y, Bakalkin G, and Ekstrom TJ. (2007) Validation of endogenous controls for quantitative gene expression analysis: application on brain cortices of human chronic alcoholics. Brain research. 1132: 20-28.


Kashem MA, James G, Harper C, Wilce P, and Matsumoto I. (2007) Differential protein expression in the corpus callosum (splenium) of human alcoholics: a proteomics study. Neurochem Int. 50: 450-459.


McCullumsmith RE, Kristiansen LV, Beneyto M, Scarr E, Dean B, and Meador-Woodruff JH. (2007) Decreased NR1, NR2A, and SAP102 transcript expression in the hippocampus in bipolar disorder. Brain research. 1127: 108-118.


Morahan JM, Yu B, Trent RJ, and Pamphlett R. (2007) Are metallothionein genes silenced in ALS? Toxicol Lett. 168: 83-87.


Newell KA, Zavitsanou K, Jew SK, and Huang XF. (2007) Alterations of muscarinic and GABA receptor binding in the posterior cingulate cortex in schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry. 31: 225-233.


Oates N, Pamphlett R. (2007). An epigenetic analysis of SOD1 and VEGF in ALS. Amyotroph Lateral Scler 8:83-86.


Oates N, and Pamphlett R. (2007) An epigenetic analysis of SOD1 and VEGF in ALS. Amyotroph Lateral Scler. 8: 83-86.


Okvist A, Johansson S, Kuzmin A, Bazov I, Merino-Martinez R, Ponomarev I, Mayfield RD, Harris RA, Sheedy D, Garrick T, Harper C, Hurd YL, Terenius L, Ekstrom TJ, Bakalkin G, and Yakovleva T. (2007) Neuroadaptations in human chronic alcoholics: dysregulation of the NF-κB system. PLoS ONE. 2: e930.


Raedler TJ, Bymaster FP, Tandon R, Copolov D, and Dean B. (2007) Towards a muscarinic hypothesis of schizophrenia. Mol Psychiatr. 12: 232-246.


Saunderson RB, Yu B, Trent RJ, and Pamphlett R. (2007) Low yield in screening patients with sporadic motor neuron disease for Kennedy disease. Intern Med J. 37: 772-774.


Savage G, Ray F, Halmagyi M, Blazely A, and Harper C. (2007) Stable neuropsychological deficits in adult polyglucosan body disease. J Clin Neurosci. 14: 473-477.


Scarr E, Sundram S, Keriakous D, and Dean B. (2007) Altered hippocampal muscarinic M4, but not M1, receptor expression from subjects with schizophrenia. Biol Psychiatry. 61: 1161-1170.


Seeman P, Ko F, Jack E, Greenstein R, and Dean B. (2007) Consistent with dopamine supersensitivity, RGS9 expression is diminished in the amphetamine-treated animal model of schizophrenia and in postmortem schizophrenia brain. Synapse. 61: 303-309.


Song YJC, Huang Y, Ludvig D, Gai WP, Blumbergs P, Horup P, Otzen D, Halliday G, and Jensen P. (2007) P25α relocalizes in oligodendroglia from myelin to cytoplasmic inclusions in multiple system atrophy. Parkinsonism Relat Disord. 13: 63.


Song YJC, Lundvig DM, Huang Y, Gai WP, Blumbergs PC, Hojrup P, Otzen D, Halliday GM, and Jensen PH. (2007) p25α relocalizes in oligodendroglia from myelin to cytoplasmic inclusions in multiple system atrophy. Am J Pathol. 171: 1291-1303.


Taylor JM, Song YJ, Huang Y, Farrer MJ, Delatycki MB, Halliday GM, and Lockhart PJ. (2007) Parkin Co-Regulated Gene (PACRG) is regulated by the ubiquitin-proteasomal system and is present in the pathological features of Parkinsonian diseases. Neurobiol Dis. 27: 238-247.


Walton HS, and Dodd PR. (2007) Glutamate-glutamine cycling in Alzheimer's disease. Neurochem Int. 50: 1052-1066.


Wheeler DG, and Harper CG. (2007) Localised reductions in gyrification in the posterior cingulate: schizophrenia and controls. Prog Neuropsychopharmacol Biol Psychiatry. 31: 319-327.